November 2023
1. AVNI B, Neiman D, Shaked ED, Gal-Rosenberg O, et al
   Chronic graft versus host disease detected by tissue-specific cell-free DNA methylation biomarkers.
   J Clin Invest. 2023 Nov 16:e163541. doi: 10.1172/JCI163541.
   

   >> Share

   
   
2. LI M, Nishimura T, Takeuchi Y, Hongu T, et al
   FXYD3 functionally demarcates an ancestral breast cancer stem cell subpopulation with features of drug-tolerant persisters.
   J Clin Invest. 2023;133:e166666.
   

   >> Share

   
   
3. VAZQUEZ-ARMENDARIZ AI, Tata PR
   Recent advances in lung organoid development and applications in disease modeling.
   J Clin Invest. 2023;133:e170500.
   

   >> Share

   
   
4. LOVEWELL RR, Hong J, Kundu S, Fielder CM, et al
   LAIR-1 agonism as a therapy for acute myeloid leukemia.
   J Clin Invest. 2023;133:e169519.
   

   >> Share

   
   August 2023
5. YU C, Sheng Y, Yu F, Ni H, et al
   Foxm1 haploinsufficiency drives clonal hematopoiesis and promotes a stress-related transition to hematologic malignancy in mice.
   J Clin Invest. 2023;133:e163911.
   

   >> Share

   
   
6. LI Q, Wang X, Song Q, Yang S, et al
   Donor T cell STAT3 deficiency enables tissue PD-L1-dependent prevention of graft-versus-host disease while preserving graft-versus-leukemia activity.
   J Clin Invest. 2023;133:e165723.
   

   >> Share

   
   
7. BRANDSTADTER JD, Outen R, Maillard I
   Having it both ways: how STAT3 deficiency blocks graft-versus-host disease while preserving graft-versus-leukemia activity.
   J Clin Invest. 2023;133:e172251.
   

   >> Share

   
   
8. LOGAN BR, Fu D, Howard A, Fei M, et al
   Validated graft-specific biomarkers identify patients at risk for chronic graft-versus-host disease and death.
   J Clin Invest. 2023;133:e168575.
   

   >> Share

   
   July 2023
9. SHAH AH, Rivas SR, Doucet-O'Hare TT, Govindarajan V, et al
   Human endogenous retrovirus K contributes to a stem cell niche in glioblastoma.
   J Clin Invest. 2023;133:e167929.
   

   >> Share

   
   June 2023
10. LIN Y, Gu Q, Lu S, Pan Z, et al
    Ruxolitinib improves hematopoietic regeneration by restoring mesenchymal stromal cell function in acute graft-versus-host disease.
    J Clin Invest. 2023 Jun 20:e162201. doi: 10.1172/JCI162201.
    

    >> Share

    
    
11. PASUPULETI SK, Ramdas B, Burns SS, Palam LR, et al
    Obesity-induced inflammation exacerbates clonal hematopoiesis.
    J Clin Invest. 2023;133:e163968.
    

    >> Share

    
    May 2023
12. KERKERING J, Muinjonov B, Rosiewicz KS, Diecke S, et al
    iPSC-derived reactive astrocytes from patients with multiple-sclerosis protect cocultured neurons in inflammatory conditions.
    J Clin Invest. 2023 May 23:e164637. doi: 10.1172/JCI164637.
    

    >> Share

    
    
13. EADE KT, Ansell BRE, Giles S, Fallon R, et al
    iPSC-derived retinal pigmented epithelial cells from patients with macular telangiectasia show decreased mitochondrial function.
    J Clin Invest. 2023;133:e163771.
    

    >> Share

    
    February 2023
14. MEERMEIER EW, Bergsagel PL
    Revisiting checkpoint inhibitors for myeloma: maintenance after stem cell transplant.
    J Clin Invest. 2023;133:e167346.
    

    >> Share

    
    
15. WANG YM, Taggart CB, Huber JF, Davies SM, et al
    Daytime-restricted parenteral feeding is associated with earlier oral intake in children following stem cell transplant.
    J Clin Invest. 2023;133:e167275.
    

    >> Share

    
    January 2023
16. LEE D, Gimple RC, Wu X, Prager BC, et al
    Superenhancer activation of KLHDC8A drives glioma ciliation and hedgehog signaling.
    J Clin Invest. 2023;133:e163592.
    

    >> Share

    
    December 2022
17. CHOI KM, Kim JJ, Yoo J, Kim KS, et al
    The interferon-inducible protein viperin controls cancer metabolic reprogramming to enhance cancer progression.
    J Clin Invest. 2022;132:e157302.
    

    >> Share

    
    
18. MINNIE SA, Waltner OG, Ensbey KS, Olver SD, et al
    TIGIT inhibition and lenalidomide synergistically promote anti-myeloma immune responses after stem cell transplantation in mice.
    J Clin Invest. 2022 Dec 13:e157907. doi: 10.1172/JCI157907.
    

    >> Share

    
    November 2022
19. LU C, Ma H, Song L, Wang H, et al
    IFNGR/STAT1 signaling in recipient hematopoietic antigen presenting cells suppresses graft-versus-host disease.
    J Clin Invest. 2022 Nov 29:e125986. doi: 10.1172/JCI125986.
    

    >> Share

    
    
20. KUROKAWA K, Wang TC, Hayakawa Y
    R-spondin 3 governs secretory differentiation in the gastric oxyntic glands.
    J Clin Invest. 2022;132.
    

    >> Share

    
    October 2022
21. YIN N, Jin G, Ma Y, Zhao H, et al
    SZT2 maintains hematopoietic stem cell homeostasis via nutrient-mediated mTORC1 regulation.
    J Clin Invest. 2022;132.
    

    >> Share

    
    September 2022
22. SCHUTT S, Wu Y, Kharel A, Bastian D, et al
    The druggable transcription factor Fli-1 regulates T cell immunity and tolerance in graft-versus-host disease.
    J Clin Invest. 2022 Sep 8. pii: 143950. doi: 10.1172/JCI143950.
    

    >> Share

    
    August 2022
23. DULMOVITS BM, Olson TS
    Does immune destruction drive all forms of bone marrow failure?
    J Clin Invest. 2022;132.
    

    >> Share

    
    July 2022
24. EVANS EJ JR, DeGregori J
    Dissecting stepwise mutational impairment of megakaryopoiesis in a model of Down syndrome-associated leukemia.
    J Clin Invest. 2022;132.
    

    >> Share

    
    
25. JAKUBISON BL, Sarkar T, Gudmundsson KO, Singh S, et al
    ID2 and HIF-1alpha collaborate to protect quiescent hematopoietic stem cells from activation, differentiation, and exhaustion.
    J Clin Invest. 2022;132.
    

    >> Share

    
    June 2022
26. SELLAR RS, Sperling AS, Slabicki M, Gasser JA, et al
    Degradation of GSPT1 causes TP53-independent cell death in leukemia whilst sparing normal hematopoietic stem cells.
    J Clin Invest. 2022 Jun 28. pii: 153514. doi: 10.1172/JCI153514.
    

    >> Share

    
    
27. FERRARA J, Prado-Acosta M
    Graft-versus-host disease: establishing IL-33 as an important costimulatory molecule.
    J Clin Invest. 2022;132.
    

    >> Share

    
    
28. LIN Q, Wu L, Chatla S, Chowdhury FA, et al
    Hematopoietic stem cell regeneration through paracrine regulation of the Wnt5a/Prox1 signaling axis.
    J Clin Invest. 2022;132.
    

    >> Share

    
    
29. GASPARINI SJ, Tessmer K, Reh M, Wieneke S, et al
    Transplanted human cones incorporate into the retina and function in a murine cone degeneration model.
    J Clin Invest. 2022;132.
    

    >> Share

    
    
30. CASADO JA, Valeri A, Sanchez-Dominguez R, Vela P, et al
    Upregulation of NKG2D ligands impairs hematopoietic stem cell function in Fanconi anemia.
    J Clin Invest. 2022 Jun 7. pii: 142842. doi: 10.1172/JCI142842.
    

    >> Share

    
    
31. WICKS EE, Semenza GL
    Hypoxia-inducible factors: cancer progression and clinical translation.
    J Clin Invest. 2022;132.
    

    >> Share

    
    
32. LIANG J, Huang G, Liu X, Taghavifar F, et al
    The ZIP8/SIRT1 axis regulates alveolar progenitor cell renewal in aging and idiopathic pulmonary fibrosis.
    J Clin Invest. 2022;132.
    

    >> Share

    
    May 2022
33. KTENA YP, Koldobskiy MA, Barbato MI, Fu HH, et al
    Donor T-cell DNMT3a regulates alloreactivity in murine models of hematopoietic stem cell transplantation.
    J Clin Invest. 2022 May 24. pii: 158047. doi: 10.1172/JCI158047.
    

    >> Share

    
    
34. DWYER GK, Mathews LR, Villegas JA, Lucas A, et al
    IL-33 acts as a costimulatory signal to generate alloreactive Th1 cells in graft-versus-host disease.
    J Clin Invest. 2022 May 3. pii: 150927. doi: 10.1172/JCI150927.
    

    >> Share

    
    February 2022
35. JIANG L, Hao Y, Shao C, Wu Q, et al
    ADAR1-mediated RNA editing links ganglioside catabolism to glioblastoma stem cell maintenance.
    J Clin Invest. 2022 Feb 8. pii: 143397. doi: 10.1172/JCI143397.
    

    >> Share

    
    
36. BUTLER PC, Gale EA
    Reversing type 1 diabetes with stem cell-derived islets: a step closer to the dream?
    J Clin Invest. 2022;132.
    

    >> Share

    
    
37. SEEBAUER CT, Graus MS, Huang L, McCann A, et al
    Non-beta blocker enantiomers of propranolol and atenolol inhibit vasculogenesis in infantile hemangioma.
    J Clin Invest. 2022;132.
    

    >> Share

    
    January 2022
38. GUAN Y, Hasipek M, Jiang D, Tiwari AD, et al
    Eltrombopag inhibits TET dioxygenase to contribute to hematopoietic stem cell expansion in aplastic anemia.
    J Clin Invest. 2022 Jan 27. pii: 149856. doi: 10.1172/JCI149856.
    

    >> Share

    
    
39. OLIVA AD, Gupta R, Issa K, Abi Hachem R, et al
    Aging-related olfactory loss is associated with olfactory stem cell transcriptional alterations in humans.
    J Clin Invest. 2022 Jan 6. pii: 155506. doi: 10.1172/JCI155506.
    

    >> Share

    
    
40. LI Z, Duan H, Jia Y, Zhao C, et al
    Long-term corneal recovery by simultaneous delivery of hPSC-derived corneal endothelial precursors and nicotinamide.
    J Clin Invest. 2022;132.
    

    >> Share

    
    November 2021
41. PERSAUD SP, Ritchey JK, Kim S, Lim S, et al
    Antibody-drug conjugates plus Janus kinase inhibitors enable MHC-mismatched allogeneic hematopoietic stem cell transplantation.
    J Clin Invest. 2021 Nov 2. pii: 145501. doi: 10.1172/JCI145501.
    

    >> Share

    
    
42. TOKARZ VL, Delgado-Olguin P, Klip A
    Deprogram and reprogram to solve the riddle of insulin resistance.
    J Clin Invest. 2021;131.
    

    >> Share

    
    
43. BRAEUER RR, Walker NM, Misumi K, Mazzoni-Putman S, et al
    Transcription factor FOXF1 identifies compartmentally distinct mesenchymal cells with a role in lung allograft fibrogenesis.
    J Clin Invest. 2021;131.
    

    >> Share

    
    October 2021
44. CHEN Z, Lu T, Huang L, Wang Z, et al
    Circular RNA cia-MAF drives self-renewal and metastasis of liver tumor-initiating cells via transcription factor MAFF.
    J Clin Invest. 2021;131.
    

    >> Share

    
    August 2021
45. QIAN J, LeSavage BL, Hubka KM, Ma C, et al
    Cancer-associated mesothelial cells promote ovarian cancer chemoresistance through paracrine osteopontin signaling.
    J Clin Invest. 2021;131.
    

    >> Share

    
    June 2021
46. TANG XY, Xu L, Wang J, Hong Y, et al
    DSCAM/PAK1 pathway suppression reverses neurogenesis deficits in iPSC-derived cerebral organoids from patients with Down syndrome.
    J Clin Invest. 2021;131.
    

    >> Share

    
    
47. LOONG JH, Wong TL, Tong M, Sharma R, et al
    Glucose deprivation-induced aberrant FUT1-mediated fucosylation drives cancer stemness in hepatocellular carcinoma.
    J Clin Invest. 2021;131.
    

    >> Share

    
    April 2021
48. WANG L, Liu Y, Stratigopoulos G, Panigrahi S, et al
    Bardet-Biedl syndrome proteins regulate intracellular signaling and neuronal function in patient-specific iPSC-derived neurons.
    J Clin Invest. 2021;131.
    

    >> Share

    
    March 2021
49. MUSCARELLA AM, Aguirre S, Hao X, Waldvogel SM, et al
    Exploiting bone niches: progression of disseminated tumor cells to metastasis.
    J Clin Invest. 2021;131.
    

    >> Share

    
    
50. OSUKA S, Zhu D, Zhang Z, Li C, et al
    N-cadherin upregulation mediates adaptive radioresistance in glioblastoma.
    J Clin Invest. 2021;131.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share